Lu, X <br/><br/>
The impact of p53 status on cellular sensitivity to antifolate drugs.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Jul 2001 
 - 2114-23 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Cell Cycle--drug effects<br/>Cell Division--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclins--genetics<br/>DNA Mutational Analysis<br/>DNA, Neoplasm--chemistry<br/>Dose-Response Relationship, Drug<br/>Folic Acid Antagonists--pharmacology<br/>Gene Expression Regulation, Neoplastic--radiation effects<br/>Genotype<br/>Glutamates--pharmacology<br/>Guanine--analogs & derivatives<br/>Humans<br/>Methotrexate--pharmacology<br/>Mutation<br/>Pemetrexed<br/>Quinazolines--pharmacology<br/>Sensitivity and Specificity<br/>Tetrahydrofolates--pharmacology<br/>Thiophenes--pharmacology<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Protein p53--genetics